David Berard Smith

Title: David Berard Smith: Innovator in Pharmaceutical Chemistry

Introduction

David Berard Smith is a notable inventor based in San Mateo, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body. With a total of two patents to his name, Smith's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Smith's latest patents include innovations related to piperidine quaternary salts and their applications as CCR-3 receptor antagonists. These inventions focus on 4-aroylpiperidine derivatives that serve as CCR-3 receptor antagonists. The patents detail pharmaceutical compositions containing these compounds, methods for their use, and methods for preparing them. This research is crucial for advancing treatments that involve the CCR-3 receptor.

Career Highlights

David Berard Smith is associated with Syntex (U.S.A.) Inc., where he has been instrumental in developing new pharmaceutical solutions. His expertise in chemistry and innovative thinking has led to advancements in drug development processes. Smith's work exemplifies the intersection of scientific research and practical application in the pharmaceutical industry.

Collaborations

Throughout his career, Smith has collaborated with talented individuals such as Denis John Kertesz and Leyi Gong. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

David Berard Smith's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options, demonstrating the importance of innovation in medicine.